knowledge -WSS

knowledge

author：focus 2025-10-01 05:39:45 - browse：4591

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

For more on what we cover, here’s the story on gene therapy; here’s more on Ipsen’s treatment for FOP; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： NIH tests clinical research in primary care with $30 million program

WSS

Why failed clinical trials don’t always spell doom for a new drug

South Korea throws huge K

South Korea throws huge K

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

The best solution to the drug shortages problem

focus

knowledge

Wikipedia

How one medical school became remarkably diverse

The system is set up to fail children with medical complexity

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Bright Health sells Medicare Advantage business to Molina

Study: Why relieving medical debt did not improve financial outcomes

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Study: Why relieving medical debt did not improve financial outcomes

What does generative AI mean for health care? We asked experts

What to know about Virgin Galactic's 1st mission taking paying customers to space

focus

Drastic changes should bring profitability, startup health insurers say

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

In same hospitals, Black patients receive fewer opioids than white patients

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

NIH trials fail to test meaningful long Covid therapies, experts say

Lilly's Alzheimer's drug donanemab backed by FDA advisers

focus

hotspot

Wikipedia

Wikipedia